| Novi M, Lauritano EC, Piscaglia AC, et al. Portal Vein Tumor Thrombosis Revascularization During Sorafenib Treatment for Hepatocellular Carcinoma. [JOURNAL ARTICLE] Am J Gastroenterol 2009 Jul; 104(7):1852-1854. Full Citation |
| Simard JR, Getlik M, Grütter C, et al. Development of a Fluorescent-Tagged Kinase Assay System for the Detection and Characterization of Allosteric Kinase Inhibitors. [JOURNAL ARTICLE] J Am Chem Soc 2009 Jun 1. Abstract | Full Citation |
| Frieling T, Heise J, Wassilew SW Multiple colon ulcerations, perforation and death during treatment of malignant melanoma with sorafenib. [Journal Article] Dtsch Med Wochenschr 2009 Jul; 134(28-29):e1-2, 1464. Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Daniele B, Di Maio M Target therapy for hepatocellular carcinoma: is sorafenib for everybody? [Journal Article] J Clin Gastroenterol 2009 May-Jun; 43(5):389-90. Full Citation | Find Related Articles |
| Horger M, Lauer UM, Schraml C, et al. Early MRI response monitoring of patients with advanced hepatocellular carcinoma under treatment with the multikinase inhibitor sorafenib. [JOURNAL ARTICLE] BMC Cancer 2009 Jun 28; 9(1):208. Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Lee WJ, Lee JL, Chang SE, et al. Cutaneous adverse effects in patients treated with the multitargeted kinase inhibitors sorafenib and sunitinib. [JOURNAL ARTICLE] Br J Dermatol 2009 May 5. Abstract | Full Citation | Find Related Articles |
| Tomillero A, Moral MA Gateways to clinical trials. [Journal Article] Methods Find Exp Clin Pharmacol 2009 May; 31(4):263-98. Abstract | Full Citation |
| Heng DY, Choueiri TK Non-clear cell renal cancer: features and medical management. [Journal Article] J Natl Compr Canc Netw 2009 Jun; 7(6):659-65. Abstract | Full Citation | Find Related Articles |
| Saylor PJ, Michaelson MD New treatments for renal cell carcinoma: targeted therapies. [Journal Article] J Natl Compr Canc Netw 2009 Jun; 7(6):645-56. Abstract | Full Citation | Find Related Articles |
| Brüning A, Burger P, Vogel M, et al. Nelfinavir induces mitochondria protection by ERK1/2-mediated mcl-1 stabilization that can be overcome by sorafenib. [JOURNAL ARTICLE] Invest New Drugs 2009 Jun 26. Abstract | Full Citation | Publisher Full Text | Find Related Articles |
 |